Large-scale testing (Phase 3)Study completedNCT03903562
What this trial is testing
Immunobridging Study of 9- Valent Human Papillomavirus (9vHPV) Vaccine (V503) in Chinese Females 9 to 45 Years of Age (V503-024)
Who this might be right for
Papillomavirus Infections
Merck Sharp & Dohme LLC 1,990